VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$8.86B
1-Year Return
26.43%
This Quarter Return
-2.18%
1 Year Return
+26.43%
3 Year Return
+118.27%
5 Year Return
+211.61%
10 Year Return
–
AUM
$6.78B
AUM Growth
+$161M
(+2.4%)
Cap. Flow
+$471M
Cap. Flow
% of AUM
6.95%
Top 10 Holdings %
Top 10 Hldgs %
28.84%
Holding
1,935
New
129
Increased
1,230
Reduced
459
Closed
96
Top Buys
| 1 |
Apple
AAPL
|
$27.3M |
| 2 |
NVIDIA
NVDA
|
$13M |
| 3 |
Amazon
AMZN
|
$11.5M |
| 4 |
Johnson & Johnson
JNJ
|
$11.5M |
| 5 |
Meta Platforms (Facebook)
META
|
$8.49M |
Top Sells
| 1 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$1.66M |
| 2 |
Vanguard Total World Stock ETF
VT
|
$1.57M |
| 3 |
General Mills
GIS
|
$1.25M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
$1.08M |
| 5 |
Lockheed Martin
LMT
|
$889K |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Financials | 14.94% |
| 3 | Healthcare | 10.98% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Sana Biotechnology
SANA
$744M
| $30.5K | ﹤0.01% |
18,158
-36
| -0.2% | -$60 |
|
|
LAC
1727
Lithium Americas
LAC
$703M
| $30.4K | ﹤0.01% |
11,225
-1,771
| -14% | -$4.8K |
|
1728
Prime Medicine
PRME
$695M
| $30.3K | ﹤0.01% |
15,237
+2,859
| +23% | +$5.69K |
|
1729
Fulcrum Therapeutics
FULC
$405M
| $29.6K | ﹤0.01% |
+10,266
| New | +$29.6K |
|
1730
Kyverna Therapeutics
KYTX
$166M
| $29.5K | ﹤0.01% |
+15,275
| New | +$29.5K |
|
|
AGEN
1731
Agenus
AGEN
$135M
| $29K | ﹤0.01% |
19,247
+4,775
| +33% | +$7.19K |
|
|
AUTL
1732
Autolus Therapeutics
AUTL
$391M
| $28.8K | ﹤0.01% |
+18,611
| New | +$28.8K |
|
|
BITF
1733
Bitfarms
BITF
$707M
| $28.3K | ﹤0.01% |
35,944
+12,833
| +56% | +$10.1K |
|
1734
Quantum-Si Incorporated
QSI
$219M
| $28.2K | ﹤0.01% |
23,477
+3,532
| +18% | +$4.24K |
|
1735
Olaplex Holdings
OLPX
$961M
| $28.1K | ﹤0.01% |
22,129
-3,691
| -14% | -$4.69K |
|
1736
Televisa
TV
$1.54B
| $27.9K | ﹤0.01% |
15,961
-1,142
| -7% | -$2K |
|
1737
ProQR Therapeutics
PRQR
$241M
| $27.7K | ﹤0.01% |
20,796
-633
| -3% | -$842 |
|
|
BLDP
1738
Ballard Power Systems
BLDP
$580M
| $27.5K | ﹤0.01% |
24,977
-18,692
| -43% | -$20.6K |
|
1739
Sight Sciences
SGHT
$194M
| $27.4K | ﹤0.01% |
+11,435
| New | +$27.4K |
|
|
OPI
1740
Office Properties Income Trust
OPI
$16.9M
| $27.2K | ﹤0.01% |
59,619
+17,602
| +42% | +$8.03K |
|
1741
TrueCar
TRUE
$188M
| $27.1K | ﹤0.01% |
+17,120
| New | +$27.1K |
|
1742
Zentalis Pharmaceuticals
ZNTL
$120M
| $27K | ﹤0.01% |
16,966
+911
| +6% | +$1.45K |
|
1743
Cabaletta Bio
CABA
$155M
| $26.8K | ﹤0.01% |
19,379
+966
| +5% | +$1.34K |
|
1744
Ventyx Biosciences
VTYX
$173M
| $26.3K | ﹤0.01% |
22,883
+5,939
| +35% | +$6.83K |
|
1745
Holley
HLLY
$462M
| $26.3K | ﹤0.01% |
10,225
+78
| +0.8% | +$200 |
|
1746
Rani Therapeutics
RANI
$24.3M
| $25.8K | ﹤0.01% |
+20,439
| New | +$25.8K |
|
1747
AXT Inc
AXTI
$151M
| $25.6K | ﹤0.01% |
+18,151
| New | +$25.6K |
|
1748
Neumora Therapeutics
NMRA
$267M
| $25.3K | ﹤0.01% |
+25,274
| New | +$25.3K |
|
1749
AbCellera Biologics
ABCL
$1.24B
| $25.2K | ﹤0.01% |
11,322
-11,055
| -49% | -$24.7K |
|
1750
Nektar Therapeutics
NKTR
$806M
| $25.1K | ﹤0.01% |
2,458
+1,335
| +119% | +$13.6K |
|